116 related articles for article (PubMed ID: 21855629)
1. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.
Kapuria V; Levitzki A; Bornmann WG; Maxwell D; Priebe W; Sorenson RJ; Showalter HD; Talpaz M; Donato NJ
Cell Signal; 2011 Dec; 23(12):2076-85. PubMed ID: 21855629
[TBL] [Abstract][Full Text] [Related]
2. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
[TBL] [Abstract][Full Text] [Related]
3. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.
Kapuria V; Peterson LF; Fang D; Bornmann WG; Talpaz M; Donato NJ
Cancer Res; 2010 Nov; 70(22):9265-76. PubMed ID: 21045142
[TBL] [Abstract][Full Text] [Related]
5. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
Nishioka C; Ikezoe T; Yang J; Takeuchi S; Koeffler HP; Yokoyama A
Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells.
Qian C; Wang J; Yao J; Wang L; Xue M; Liu W; Si J
Anat Rec (Hoboken); 2013 Dec; 296(12):1865-73. PubMed ID: 24151255
[TBL] [Abstract][Full Text] [Related]
7. WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
Verstovsek S; Manshouri T; Quintás-Cardama A; Harris D; Cortes J; Giles FJ; Kantarjian H; Priebe W; Estrov Z
Clin Cancer Res; 2008 Feb; 14(3):788-96. PubMed ID: 18245540
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through activation of the Jak2 tyrosine kinase pathway in vascular endothelial cells.
Shimizu S; Hiroi T; Ishii M; Hagiwara T; Wajima T; Miyazaki A; Kiuchi Y
Int J Biochem Cell Biol; 2008; 40(4):755-65. PubMed ID: 18054268
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of JAK2 by serotonin 5-HT (2A) receptor activates both STAT3 and ERK1/2 pathways and increases growth of JEG-3 human placental choriocarcinoma cell.
Oufkir T; Vaillancourt C
Placenta; 2011 Dec; 32(12):1033-40. PubMed ID: 21993263
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors.
Yang SH; Khadka DB; Cho SH; Ju HK; Lee KY; Han HJ; Lee KT; Cho WJ
Bioorg Med Chem; 2011 Jan; 19(2):968-77. PubMed ID: 21185195
[TBL] [Abstract][Full Text] [Related]
11. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
12. [Effect of homoharringtonine combined with AG490 on JAK2-STAT5 associated signal pathway in HEL cells].
Ren YL; Tong HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1117-20. PubMed ID: 22040954
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma.
Peng Z; Pal A; Han D; Wang S; Maxwell D; Levitzki A; Talpaz M; Donato NJ; Bornmann W
Bioorg Med Chem; 2011 Dec; 19(23):7194-204. PubMed ID: 22036213
[TBL] [Abstract][Full Text] [Related]
14. JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene 1 expression.
Shen XL; Wei W; Xu HL; Zhang MX; Qin XQ; Shi WZ; Jiang ZP; Chen YJ; Chen FP
Biochem Biophys Res Commun; 2010 Aug; 398(4):707-12. PubMed ID: 20621061
[TBL] [Abstract][Full Text] [Related]
15. A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry.
Bareng J; Jilani I; Gorre M; Kantarjian H; Giles F; Hannah A; Albitar M
Leuk Lymphoma; 2007 Nov; 48(11):2189-95. PubMed ID: 17926180
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Yisui Jiedu Recipe on JAK2-STAT5 signal transduction pathway in bone marrow hematopoietic cells from patients with myelodysplastic syndrome-refractory anemia].
Tian SL; Zhou YM; Huang T; Xue ZZ; He W
Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):185-9. PubMed ID: 18241656
[TBL] [Abstract][Full Text] [Related]
17. [Effect of JAK2/STAT3/vimentin signaling pathway on proliferation and migration of human colon cancer cells].
Xu JH; Zhang C; Tang B; Hao YX; Chen J; Liu T; Cui H
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):282-5. PubMed ID: 20422486
[TBL] [Abstract][Full Text] [Related]
18. Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction.
Liu CS; Yang-Yen HF; Suen CS; Hwang MJ; Yen JJ
Sci Rep; 2017 Jul; 7(1):4613. PubMed ID: 28676638
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT.
Ross SL; Tran L; Winters A; Lee KJ; Plewa C; Foltz I; King C; Miranda LP; Allen J; Beckman H; Cooke KS; Moody G; Sasu BJ; Nemeth E; Ganz T; Molineux G; Arvedson TL
Cell Metab; 2012 Jun; 15(6):905-17. PubMed ID: 22682226
[TBL] [Abstract][Full Text] [Related]
20. Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
Leukemia; 2009 Dec; 23(12):2304-8. PubMed ID: 19675589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
